Smith+Nephew completed the acquisition of CartiHeal for $330m.

Smith+Nephew, the global medical technology company, completed the acquisition of CartiHeal, developer of Agili-C, a novel sports medicine technology for cartilage regeneration in the knee, for $330m. “With its proven superiority2 to current standard of care, Agili-C has the potential to transform cartilage repair outcomes. Our expertise in regenerative therapy and leadership in knee repair gives me great confidence that this will be a significant value creator for Smith+Nephew," Scott Schaffner, Smith+Nephew President Sports Medicine.